Revolution Medicines Inc

RVMDNASDAQ · USD
182.67USD-1.23 (-0.67%)
1210

Revolution Medicines Inc (RVMD) Options Open Interest

RVMD options open interest is 54,350 contracts. The 2-week average daily volume is 2,222 contracts across the chain.

Read more

Monitoring RVMD open interest helps you see where real money is positioned on Revolution Medicines Inc's options and which strikes are attracting the most commitment from traders. Revolution Medicines Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor RVMD options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising RVMD options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Revolution Medicines Inc to settle.

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants.

Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where RVMD open interest is concentrated. Our scanner maps Revolution Medicines Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Revolution Medicines Inc's options open interest as the signal it is, not as an afterthought.

2026-11-20
Calls
210.004.707.506.1068%+0.30301,614
220.002.505.504.0068%+0.2201463
230.001.602.802.2064%+0.1414420
200.007.0010.008.5066%+0.3945302
240.001.002.901.9571%+0.1191109
Puts
150.000.351.751.0559%-0.07274,041
175.005.409.207.3064%-0.31433,025
170.003.707.405.5564%-0.25771,239
185.009.4013.1011.2562%-0.434296
160.001.004.902.9564%-0.158984

As of October 26, 2026

Follow the money

Track RVMD open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial